Cargando…
Radioimmunotherapy study of (131)I-labeled Atezolizumab in preclinical models of colorectal cancer
BACKGROUND: Programmed cell death 1 ligand 1(PD-L1) is overexpressed in many tumors. The radionuclide-labeled anti-PD-L1 monoclonal antibody can be used for imaging and therapy of PD-L1 overexpressing cancer. Here, we described (131)I-labeled Atezolizumab ((131)I-Atezolizumab, targeting PD-L1) as a...
Autores principales: | Zhang, Linhan, Zhao, Sheng, Jiang, Huijie, Zhang, Rongjun, Zhang, Mingyu, Pan, Wenbin, Sun, Zhongqi, Wang, Dandan, Li, Jinping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616992/ https://www.ncbi.nlm.nih.gov/pubmed/36307610 http://dx.doi.org/10.1186/s13550-022-00939-2 |
Ejemplares similares
-
Near‐infrared fluorescence‐labeled anti‐PD‐L1‐mAb for tumor imaging in human colorectal cancer xenografted mice
por: Zhang, Mingyu, et al.
Publicado: (2019) -
Radioimmunotherapy of human hepatocellular carcinoma xenografts with 131I-labelled antiferritin antibody.
por: Saiful Alam, A. F.
Publicado: (1991) -
Radioimmunotherapy of transplanted small cell lung cancer with 131I-labelled monoclonal antibody.
por: Yoneda, S., et al.
Publicado: (1988) -
Preclinical in vivo application of (152)Tb-DOTANOC: a radiolanthanide for PET imaging
por: Müller, Cristina, et al.
Publicado: (2016) -
Filming a live cell by scanning electrochemical microscopy: label-free imaging of the dynamic morphology in real time
por: Zhang, Michelle Meng-Ni, et al.
Publicado: (2012)